FI55664B - Foerfarande foer framstaellning av blodtryckssaenkande 5-oxo-2,3-dihydro-imidazo(1,2-a)-s-triaziner - Google Patents

Foerfarande foer framstaellning av blodtryckssaenkande 5-oxo-2,3-dihydro-imidazo(1,2-a)-s-triaziner

Info

Publication number
FI55664B
FI55664B FI822/74A FI82274A FI55664B FI 55664 B FI55664 B FI 55664B FI 822/74 A FI822/74 A FI 822/74A FI 82274 A FI82274 A FI 82274A FI 55664 B FI55664 B FI 55664B
Authority
FI
Finland
Prior art keywords
triaziner
blodtryckssaenkande
imidazo
dihydro
oxo
Prior art date
Application number
FI822/74A
Other languages
English (en)
Other versions
FI55664C (fi
Inventor
Helmut Staehle
Herbert Koeppe
Werner Kummer
Wolfgang Hoefke
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Application granted granted Critical
Publication of FI55664B publication Critical patent/FI55664B/fi
Publication of FI55664C publication Critical patent/FI55664C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
FI822/74A 1973-03-23 1974-03-19 Foerfarande foer framstaellning av blodtryckssaenkande 5-oxo-2,3-dihydro-imidazo-(1,2-a)-s-triaziner FI55664C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2314488A DE2314488C3 (de) 1973-03-23 1973-03-23 8-(2,6-Dichlorphenyl)-7-(4-chlorphenyl)-5-oxo-233,8-tetrahydro-imidazo [1,2-a] -s-triazin, Verfahren zu dessen Herstellung und dieses enthaltene Arzneimittel

Publications (2)

Publication Number Publication Date
FI55664B true FI55664B (fi) 1979-05-31
FI55664C FI55664C (fi) 1979-09-10

Family

ID=5875651

Family Applications (1)

Application Number Title Priority Date Filing Date
FI822/74A FI55664C (fi) 1973-03-23 1974-03-19 Foerfarande foer framstaellning av blodtryckssaenkande 5-oxo-2,3-dihydro-imidazo-(1,2-a)-s-triaziner

Country Status (26)

Country Link
US (1) US3887552A (fi)
JP (1) JPS5821634B2 (fi)
AT (1) AT331256B (fi)
BE (1) BE812736A (fi)
BG (2) BG23750A3 (fi)
CA (1) CA1017339A (fi)
CH (2) CH588492A5 (fi)
CS (1) CS191229B2 (fi)
DD (1) DD112266A5 (fi)
DE (1) DE2314488C3 (fi)
DK (1) DK139519C (fi)
ES (2) ES424346A1 (fi)
FI (1) FI55664C (fi)
FR (1) FR2222100B1 (fi)
GB (1) GB1455356A (fi)
HU (1) HU171082B (fi)
IE (1) IE39965B1 (fi)
IL (1) IL44470A (fi)
NL (1) NL179479C (fi)
NO (1) NO139049C (fi)
PL (2) PL88663B1 (fi)
RO (2) RO63042A (fi)
SE (1) SE419087B (fi)
SU (2) SU496734A3 (fi)
YU (2) YU36959B (fi)
ZA (1) ZA741864B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1428269A (en) * 1973-11-07 1976-03-17 Ici Ltd Pyrimidino-triazine compounds and their use as pesticides
US4289778A (en) * 1977-12-27 1981-09-15 Eli Lilly And Company 2-(Substituted imino)-N-(3-substituted phenyl)-3-thiazolidinecarbothioamides
JPS6050207U (ja) * 1983-09-09 1985-04-09 ビ−・エス・コンクリ−ト株式会社 桁下の吊り足場
JPS61246273A (ja) * 1985-04-25 1986-11-01 Dainippon Ink & Chem Inc 顔料ベ−スト

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791025A (fr) * 1971-11-19 1973-05-07 Allen & Hanburys Ltd Composes heterocycliques

Also Published As

Publication number Publication date
PL92111B1 (fi) 1977-03-31
HU171082B (hu) 1977-11-28
CH584714A5 (fi) 1977-02-15
NO139049B (no) 1978-09-18
NL179479B (nl) 1986-04-16
SE419087B (sv) 1981-07-13
NL179479C (nl) 1986-09-16
DE2314488B2 (de) 1978-05-11
YU36959B (en) 1984-08-31
ES424346A1 (es) 1976-06-01
CA1017339A (en) 1977-09-13
BG23750A3 (en) 1977-10-12
FR2222100B1 (fi) 1977-11-10
YU79074A (en) 1982-06-18
DK139519C (da) 1979-08-20
AU6703774A (en) 1975-09-25
ZA741864B (en) 1975-11-26
CS191229B2 (en) 1979-06-29
IE39965B1 (en) 1979-02-14
US3887552A (en) 1975-06-03
SU519135A3 (ru) 1976-06-25
RO63042A (fr) 1978-05-15
NO741044L (no) 1974-09-24
YU36961B (en) 1984-08-31
DE2314488A1 (de) 1974-10-03
AT331256B (de) 1976-08-10
GB1455356A (en) 1976-11-10
PL88663B1 (fi) 1976-09-30
NL7403893A (fi) 1974-09-25
DK139519B (da) 1979-03-05
JPS5821634B2 (ja) 1983-05-02
DE2314488C3 (de) 1979-01-04
SU496734A3 (ru) 1975-12-25
FR2222100A1 (fi) 1974-10-18
IL44470A (en) 1977-08-31
FI55664C (fi) 1979-09-10
ATA193674A (de) 1975-11-15
BG23006A3 (fi) 1977-05-20
IL44470A0 (en) 1974-06-30
IE39965L (en) 1974-09-23
YU176380A (en) 1982-06-18
ES424345A1 (es) 1976-06-01
CH588492A5 (fi) 1977-06-15
NO139049C (no) 1979-01-03
BE812736A (fr) 1974-09-23
DD112266A5 (fi) 1975-04-05
RO68650A (ro) 1980-04-15
JPS49135991A (fi) 1974-12-27

Similar Documents

Publication Publication Date Title
SE402592B (sv) Forfarande for framstellning av 2-alkyl-3-acyl-pyrazolo(1,5-a)pyridiner
FI54125B (fi) Foerfarande foer framstaellning av anti-inflammatoriska tetrahydropyrano(3,4-b)indol-1-aettiksyraderivat
IE37056L (en) PYRROLO [3,4-b] PYRAZINES
SE7710600L (sv) Forfarande for framstellning av 1,3-bensoxazoler
BE809169A (fr) Derives de la famille des delta 2-prostaglandines
FI54121C (fi) Foerfarande foer framstaellning av blodtryckssaenkande imidazo-(1,2-a)-imidazoler -pyrimidiner och diazepiner och deras syraadditionssalter
NO143531C (no) Fremgangsmaate for fremstilling av acylerte benzoksazolinon-derivater.
BE813021A (fr) Nouveaux derives de pyrido(1
NO146596C (no) Fremgangsmaate for fremstilling av 6-deoksytetracykliner
BE820656A (fr) Derive de la s-triazolo (1,5-a) pyridine
SE417601B (sv) Forfarande for framstellning av amidinokarbamider
SE416176B (sv) Forfarande for framstellning av hogdoserade autibiotikatabletter
NO153806C (no) Fremgangsmaate for fremstilling av 6-deoksytetracyklin.
AR192347A1 (es) Procedimiento para la preparacion de 3-amino-imidazo(1,5-a)piridinas
FI55664B (fi) Foerfarande foer framstaellning av blodtryckssaenkande 5-oxo-2,3-dihydro-imidazo(1,2-a)-s-triaziner
CH551431A (fr) Preparation de derives de la pyrrolo (3,4-b) pyridine.
SE380527B (sv) Forfarande for framstellning av 1oh-tieno(3,2-c)(1)-bensazepinderivat
FI55658C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara pyrimido(4,5-b)kinolin-4(3h)-on-2-karboxylsyraderivat
SE400768B (sv) Forfarande for framstellning av 2-fenyl-6-sulfamoyl-7-klor-1,2,3,4-tetrahydro-4-kinazolinon
SE431451B (sv) Forfarande for framstellning av 2,3-dihydroxipropoxikinoliner eller -isokinoliner
FI55660B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara pyrazolo(3,4-b)pyridinderivat
SE399895B (sv) Forfarande for framstellning av s-triazolo(3,4-b)benstiazoler
BE812061A (fr) Imidazo(1
FI56386B (fi) Foerfarande foer framstaellning av oktahydro-oxazolo 3,2-a pyrrolo 2,1-c pyrazin-derivat
FI781797A (fi) Foerfarande foer framstaellning av imidazo (1,2-a) pyridiner